Saturday 17 October 2026
Export MNTRQ’s income statement to Excel — free account
9 Meters Biopharma, Inc.
MNTRQ Healthcare Biotechnology
Follow MNTRQ
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | — | — | — | — | — | — |
P/E ratio |
0.00 | — | — | — | — | — | — |
P/S ratio |
2.38 | — | — | — | — | — | — |
P/FCF ratio |
0.00 | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(21.65) | — | — | — | — | — | — |
P/Operating CF |
(4.41) | — | — | — | — | — | — |
Beneish M-Score |
(0.08) | — | — | — | — | — | — |
P/B ratio |
3.88 | — | — | — | — | — | — |
Price to Tangible BV |
136.06 | — | — | — | — | — | — |
EV/Sales |
2.10 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | — | — | — | — | — | — |
EV/Operating CF |
(1.01) | — | — | — | — | — | — |
EV/FCF |
(1.01) | — | — | — | — | — | — |
Quick Ratio |
0.58 | 0.03 | 0.57 | 0.31 | 5.53 | 5.56 | 0.41 |
Current Ratio |
1.01 | 0.06 | 0.63 | 0.35 | 5.68 | 5.91 | 1.08 |
Net Debt/EBITDA |
0.35 | 0.03 | 0.37 | 0.19 | 0.64 | 1.28 | 0.31 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
1.36 | 0.44 | 0.63 | 0.66 | 0.32 | 0.80 | 0.85 |
Capex/Depreciation |
0.00 | (0.85) | (0.01) | (0.01) | 0.00 | (0.24) | 0.00 |
Interest Coverage |
(7.20) | (25.60) | (2.96) | (14.00) | (15.05) | (778.85) | (15.75) |
| 387.59% | 239.63% | 305.20% | 407.57% | (545.95%) | (99.75%) | (198.92%) | |
| (111.13%) | (319.61%) | (666.30%) | (460.37%) | (276.67%) | (82.34%) | (105.05%) | |
ROIC |
(358.88%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(10,900.00%) | 95.28% | 659.33% | 279.94% | (191.64%) | (88.53%) | (1,876.45%) |
Average Days of Receivables |
76.86 | 0.00 | — | — | — | — | — |
Research and Development Expense of Revenue |
6.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
157.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.01 | — | — | — | — | — | — |
Graham Number |
0.00 | — | — | — | — | — | — |
Earnings Yield |
(50.86%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(87.24%) | — | — | — | — | — | — |
Revenue per Share |
147.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(305.33) | (8.57) | (12.25) | (10.78) | (3.67) | (2.43) | (2.87) |
Capex per Share |
0.00 | (0.07) | (0.01) | (0.01) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(305.33) | (8.64) | (12.26) | (10.79) | (3.68) | (2.43) | (2.87) |
Cash per Share |
52.64 | 0.60 | 4.63 | 2.76 | 7.17 | 3.87 | 0.98 |
Shareholders Equity per Share |
90.14 | (20.48) | (2.96) | (5.77) | 6.09 | 3.42 | 0.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
90.14 | (20.48) | (2.96) | (5.77) | 6.09 | 3.42 | 0.19 |
Free Cash Flow |
(8.43) | (5.14) | (15.18) | (17.98) | (19.41) | (29.49) | (37.25) |
Working Capital |
0.06 | (12.22) | (3.70) | (9.69) | 32.08 | 41.53 | 2.32 |
Capital Expenditures |
— | (0.04) | (0.01) | (0.01) | 0.00 | (0.01) | 0.00 |
Net Current Asset Value |
0.06 | (12.22) | (3.70) | (9.69) | 31.91 | 41.42 | 2.27 |
EV/EBIT |
0.00 | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | — | — | — | — | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
0.00 | 1.11 | 72.17 | 42.87 | 137.34 | 3.21 | 176.93 |
Cash ROIC |
(213.83%) | 43.45% | (733.56%) | 358.09% | (27.73%) | (33.29%) | (247.53%) |
Accounts Receivable Turnover |
5.42 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
5.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
3.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
29.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
121.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.75 | 0.47 | — | — | — | — | — |
Average Payables |
0.64 | 1.46 | 3.14 | 3.75 | 2.69 | 1.96 | 3.74 |
Average Inventory |
0.87 | — | — | — | — | — | — |
Average Assets |
5.59 | 3.63 | 3.63 | 5.88 | 22.23 | 44.67 | 41.66 |
Average Common Equity |
(1.60) | (4.84) | (7.92) | (6.64) | 11.26 | 36.87 | 22.00 |
Columns are period end dates